Invivyd
IVVD
Invivyd (IVVD) news
Recent news
Tern - Announces settlement with general partner of SVV2 for all claims and liabilities
AInvest Wire · 3d agoInvivyd's VYD2311 met all primary, secondary endpoints
AInvest Wire · Sep 29, 2026Invivyd, - Plans bla submission for Vyd2311 to FDA via accelerated approval program
Invivyd, Inc. (Nasdaq: IVVD) has indicated its intention to submit a Biologics License Application (BLA) for VYD2311 to the U.S. Food and Drug Administration (FDA) through the accelerated approval pathway, according to recent disclosures. The company is preparing for the submission following the…
AInvest Wire · Sep 29, 2026Invivyd, - VYD2311 demonstrates safety and tolerability superior to mRNA-based COVID-19 vaccine
AInvest Wire · Sep 29, 2026Invivyd, - VYD2311 combined with mRNA COVID-19 vaccine adds to neutralizing titers without interference
AInvest Wire · Sep 29, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.